KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 98 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $102,338 | +7.0% | 10,627 | 0.0% | 0.00% | – |
| Q2 2023 | $95,643 | -35.1% | 10,627 | +4.6% | 0.00% | – |
| Q3 2022 | $147,364 | +42.4% | 10,156 | -3.4% | 0.00% | – |
| Q2 2022 | $103,458 | -32.4% | 10,514 | -9.0% | 0.00% | – |
| Q4 2021 | $153,000 | -21.9% | 11,560 | +2.8% | 0.00% | – |
| Q3 2021 | $196,000 | -30.2% | 11,247 | -4.0% | 0.00% | – |
| Q2 2021 | $281,000 | -0.7% | 11,721 | +6.4% | 0.00% | – |
| Q1 2021 | $283,000 | +14050.0% | 11,012 | +4667.1% | 0.00% | – |
| Q2 2018 | $2,000 | 0.0% | 231 | 0.0% | 0.00% | – |
| Q1 2018 | $2,000 | 0.0% | 231 | 0.0% | 0.00% | – |
| Q4 2017 | $2,000 | 0.0% | 231 | 0.0% | 0.00% | – |
| Q3 2017 | $2,000 | -33.3% | 231 | -24.5% | 0.00% | – |
| Q2 2017 | $3,000 | 0.0% | 306 | -1.3% | 0.00% | – |
| Q1 2017 | $3,000 | 0.0% | 310 | 0.0% | 0.00% | – |
| Q4 2016 | $3,000 | – | 310 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $38,088,000 | 25.57% |
| VHCP Management III, LLC | 637,884 | $14,129,000 | 6.60% |
| Vivo Capital, LLC | 1,359,149 | $30,105,000 | 2.82% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $8,611,000 | 2.78% |
| VHCP Management II, LLC | 376,889 | $8,348,000 | 2.63% |
| Samsara BioCapital, LLC | 118,500 | $2,625,000 | 1.73% |
| ACUTA CAPITAL PARTNERS, LLC | 213,000 | $4,718,000 | 1.68% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 187,599 | $4,165,000 | 1.54% |
| Ghost Tree Capital, LLC | 300,000 | $6,645,000 | 1.38% |
| Eventide Asset Management | 1,500,000 | $33,225,000 | 1.01% |